---
category: news
title: "3 Revolutionary Stocks I'd Buy Right Now Without Hesitation"
excerpt: "It's hard to see Eli Lilly as a revolutionary stock. The pharmaceutical company was formed in 1876 by a Civil War veteran and has been in the S&P 500 since 1971. However, the company has been on the forefront of two of the biggest medical breakthroughs this year: Alzheimer's drug donanemab and diabetes drug Mounjaro (tirzepatide),"
publishedDateTime: 2022-12-08T14:16:00Z
originalUrl: "https://www.nasdaq.com/articles/3-revolutionary-stocks-id-buy-right-now-without-hesitation-3"
webUrl: "https://www.nasdaq.com/articles/3-revolutionary-stocks-id-buy-right-now-without-hesitation-3"
type: article

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

secured: "hmE8V5P+1PngGsWDzX8pgiRYu0YrH9k0Cj19oVeqeMOwUuksf01lrtpc+RMHGmX2HMcUQbT2EsMbTFdjAVj0GMDYzby1yCSwmLfr38b5qWrKx2BoIakBj6Jx8TrBwxo7Dt/BkvjKd/Svjb3LuEMjXLArZNi3UnkgckaiTdMv3nM3Mw0SK4q3S/1gYfad2omS+4fGBMI3STW3pxvdJz7c9B3hx2e5RGisbc9Fw/k8JBfxcrjMRai+VSX3bVzvOVuDlFjpRJ8TwPbzSA/4rqgXfmMweApM7PSPeKO5gH0IGLCJJb2RG0op3cs0YgYvys9/B0uftrgNhPGiZEPLgovdiB/SdUQI4gtIFuOZSHP2JOk=;43m5j1aDmsARyRG6GhDkkA=="
---

